J. Tambiah

1.3k total citations
48 papers, 812 citations indexed

About

J. Tambiah is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, J. Tambiah has authored 48 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 15 papers in Pharmacology and 12 papers in Surgery. Recurrent topics in J. Tambiah's work include Osteoarthritis Treatment and Mechanisms (24 papers), Inflammatory mediators and NSAID effects (13 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). J. Tambiah is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (24 papers), Inflammatory mediators and NSAID effects (13 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). J. Tambiah collaborates with scholars based in United States, United Kingdom and Denmark. J. Tambiah's co-authors include Yusuf Yazıcı, Nancy E. Lane, Christopher J. Swearingen, Allan Gibofsky, A. DiFrancesco, Timothy E. McAlindon, Marc C. Hochberg, John Hood, İsmail Şimşek and Nebojša Skrepnik and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The American Journal of Sports Medicine.

In The Last Decade

J. Tambiah

44 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Tambiah United States	13	554	249	226	180	94	48	812
Sarah Gill United States	9	455 0.8×	169 0.7×	165 0.7×	187 1.0×	155 1.6×	29	871
Carole Bougault France	19	514 0.9×	148 0.6×	313 1.4×	159 0.9×	85 0.9×	34	921
P. van der Kraan Netherlands	9	387 0.7×	140 0.6×	301 1.3×	113 0.6×	96 1.0×	31	708
Haoruo Jia China	13	216 0.4×	137 0.6×	179 0.8×	138 0.8×	61 0.6×	20	584
N. Ogata Japan	5	444 0.8×	106 0.4×	199 0.9×	154 0.9×	67 0.7×	7	628
Akihiro Kotani Japan	7	373 0.7×	155 0.6×	202 0.9×	194 1.1×	90 1.0×	12	715
Hideki Nakamoto Japan	12	245 0.4×	105 0.4×	156 0.7×	194 1.1×	44 0.5×	40	601
Clare Darrah United Kingdom	10	501 0.9×	160 0.6×	303 1.3×	212 1.2×	135 1.4×	15	1.0k
Natalia S. Harasymowicz United States	12	308 0.6×	73 0.3×	219 1.0×	82 0.5×	61 0.6×	20	611
Marc Fajardo United States	12	194 0.4×	70 0.3×	207 0.9×	282 1.6×	63 0.7×	17	767

Countries citing papers authored by J. Tambiah

Since Specialization

Citations

This map shows the geographic impact of J. Tambiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tambiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tambiah more than expected).

Fields of papers citing papers by J. Tambiah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Tambiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tambiah. The network helps show where J. Tambiah may publish in the future.

Co-authorship network of co-authors of J. Tambiah

This figure shows the co-authorship network connecting the top 25 collaborators of J. Tambiah. A scholar is included among the top collaborators of J. Tambiah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Tambiah. J. Tambiah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karsdal, M.A., Lucio C. Rovati, J. Tambiah, et al.. (2025). The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development. Osteoarthritis and Cartilage Open. 7(2). 100572–100572. 1 indexed citations

Yazıcı, Yusuf, J. Tambiah, Christopher J. Swearingen, et al.. (2024). Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 Study. Clinical and Experimental Rheumatology. 43(5). 854–860. 1 indexed citations

Yazıcı, Yusuf, J. Tambiah, Christopher J. Swearingen, et al.. (2024). A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. Clinical and Experimental Rheumatology. 43(5). 847–853. 2 indexed citations

Yazıcı, Yusuf, et al.. (2024). POS1177 TREATMENT WITH LORECIVIVINT LEADS TO IMPROVED LONG-TERM PATIENT ACCEPTABLE SYMPTOM STATE (PASS) COMPARED TO PLACEBO: DATA FROM PHASE 3 EXTENSION TRIAL. Annals of the Rheumatic Diseases. 83. 670–671. 1 indexed citations

Fineman, Mark, Timothy E. McAlindon, Christian Lattermann, et al.. (2023). Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study. Rheumatology and Therapy. 10(6). 1741–1752. 3 indexed citations

Karsdal, M.A., J. Tambiah, Marc C. Hochberg, et al.. (2022). Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status?. SHILAP Revista de lepidopterología. 4(3). 100262–100262. 8 indexed citations

Kennedy, S., J. Tambiah, & Nancy E. Lane. (2022). Osteoarthritis today: Lost in translation?. Best Practice & Research Clinical Rheumatology. 36(4). 101810–101810. 16 indexed citations

Oderda, Gary M., Jacob Eifer Møller, Diana Brixner, et al.. (2021). The patient journey in knee osteoarthritis-variations in diagnosis, patient characteristics, and treatment by physician specialty. Osteoarthritis and Cartilage. 29. S281–S282. 1 indexed citations

Yazıcı, Yusuf, T.E. McAlindon, Allan Gibofsky, et al.. (2021). A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Osteoarthritis and Cartilage. 29(5). 654–666. 73 indexed citations

10.

Bonafede, Machaon, et al.. (2021). Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls. ClinicoEconomics and Outcomes Research. Volume 13. 421–435. 46 indexed citations

11.

Tambiah, J., S. Kennedy, Christopher J. Swearingen, et al.. (2021). Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial. Rheumatology and Therapy. 8(2). 973–985. 14 indexed citations

12.

Şimşek, İsmail, S. Kennedy, J. Tambiah, et al.. (2020). An integrated safety analysis of lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, in subjects with knee osteoarthritis. Osteoarthritis and Cartilage. 28. S376–S377. 1 indexed citations

13.

Yazıcı, Yusuf, J. Tambiah, Sarah J. Kennedy, et al.. (2019). Comparison of intra-articular sham and vehicle injection from a phase 2b trial of SM04690, a small-molecule Wnt inhibitor, for knee osteoarthritis. Osteoarthritis and Cartilage. 27. S241–S242. 2 indexed citations

14.

Yazıcı, Yusuf, Timothy E. McAlindon, Allan Gibofsky, et al.. (2019). Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage. 27. S503–S503. 9 indexed citations

15.

Yazıcı, Yusuf, Timothy E. McAlindon, Allan Gibofsky, et al.. (2018). Results from a 52-week randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular wnt pathway inhibitor (SM04690) for the treatment of knee osteoarthritis. Osteoarthritis and Cartilage. 26. S293–S294. 17 indexed citations

16.

Yazıcı, Yusuf, et al.. (2018). Radiographic outcomes were concordant with outcome measures in rheumatology-osteoarthritis research society international (OMERACT-OARSI) strict response: post-hoc analysis from a phase 2 study of a WNT pathway inhibitor, SM04690, for knee osteoarthritis treatment. Osteoarthritis and Cartilage. 26. S244–S245. 2 indexed citations

17.

Deshmukh, V., Charlene F. Barroga, Carine Bossard, et al.. (2017). A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage. 26(1). 18–27. 176 indexed citations

18.

Tambiah, J., et al.. (2007). Can tissue adhesives and glues significantly reduce the incidence and length of postoperative air leaks in patients having lung resections?. Interactive Cardiovascular and Thoracic Surgery. 6(4). 529–533. 15 indexed citations

19.

Hunt, Ian, et al.. (2007). Massive pulmonary arteriovenous malformation presenting with tamponading haemothorax. Thorax. 62(9). 836–836. 8 indexed citations

20.

Tambiah, J. & Janet T. Powell. (2002). Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: Prevention with azithromycin. Journal of Vascular Surgery. 36(5). 1011–1017. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact